Introduction
============

Dogs has been extensively used as animal models for medical research and drug evaluation, such as studying human breast cancer carcinogenesis ([@B1]), Duchenne muscular dystrophy (DMD) ([@B20]), management of furcation defect ([@B2]), chronic myocardial infarction (MI) ([@B22]), comparative pathogenesis study of H3N2 canine influenza virus (CIV) challenged ([@B13]), long term safety and efficacy of AAV gene therapy ([@B11]). Therefore, it is critical to make sure that the dogs used as laboratory animals are free of special pathogens. In China, according to the national standard of laboratory dogs, the rabies virus (RV), canine parvovirus (CPV), canine adenovirus (CAV), and canine distemper virus (CDV) are the items that must be tested. All the laboratory dogs and their living houses should be checked up with these viruses regularly for quality monitoring. However, the currently existing detection method recommended by the industry standard is conventional PCR. To complete the whole check routine, four individual PCR should be carried out, which is time-consuming, especially when dealing with a large scale of samples.

A rapid and sensitive multiplex pathogens detection technology is needed to meet the detection requirement of monitoring the animal health status and the sanitary of their living environment. Unlike the existing multiplex PCR methods that only focus on two or three targets and cannot be adapted to high-throughput testing. The luminescent beads are a novel platform for multiplex high-throughput detection and can simultaneously detect up to 100 targets in a single reaction ([@B6]; [@B12]). This tool had been adapted for use in genetic analysis, gene expression analysis, SNP analysis, and pathogen identification ([@B3]; [@B14]; [@B23]).

The Luminex xTAG assay was designed for multiple nucleic acid detection in a single reaction through the hybridization of magnetic microspheres and PCR products ([@B4]; [@B18]). The magnetic microspheres pre-coupled with anti-MagPlex-TAG oligo-nucleotides capture the matching oligo-nucleotide presented on the 5′ end of PCR amplicons. A Luminex fluorescence reader is then used for analytical measurements of bead types. This technology is commercially available for respiratory viral pathogens and gastrointestinal pathogens for human clinical diagnoses ([@B15]; [@B8]), and barely reports on applications in veterinary research.

To fulfill the testing needs of the laboratory dog suppliers for these four viruses and canine parainfluenza virus (CPIV), a multiplex assay for rapid detection of CDV, CPV, RV, CAV, and CPIV in a single tube based on the Luminex xTAG technology was developed and validated.

Materials and Methods {#s1}
=====================

Viruses and Vaccines
--------------------

Canine distemper virus and CPV were obtained from the Institute of Animal Health, Guangdong Academy of Agricultural Sciences (Guangzhou, China). Nucleic acid genomes of canine coronavirus (CCV), pseudorabies virus (PRV), CIV subtype H3N8 and the Nobivac DHPPi vaccine against CDV, CPV, CPIV, and CAV-1 (Intervet, Boxmeer, Netherlands) were preserved by our laboratory. The rabies vaccine and the polyvalent vaccine against CDV, CPV, RV, and CPIV (WuXin Pharmaceutical, Changchun, China) were obtained from the Veterinary Epidemic Prevention Station (Dongguan, China). All viruses, nucleic acids and vaccines were stored at -80°C until use.

Clinical samples were obtained from the local veterinary clinic in Guangzhou, China. DNA and RNA were extracted using a commercial automatic nucleic acid extraction instrument (Tiangen Biotech, Beijing, China) according to the manufacturer's instructions.

Multiplex PCR
-------------

Viral genomes from the NCBI database were aligned to determine the most conserved genomic regions for each virus. Primers were designed using Primer Premier 5.0 software and inspected with the vector NTI software (**Table [1](#T1){ref-type="table"}**). All the forward primers were modified with specific oligo-nucleotide tags that enabled magnetic microsphere conjugation. The 5′ ends of reverse primers were biotinylated to enable detection using streptavidin-R-phycoerythrin (SAPE). All primers and oligo-nucleotides were analyzed with Tag-It Oligo Design Software v.3.00 and purified by high-performance liquid chromatography (Invitrogen, Guangzhou, China).

###### 

Primers used in the multiplex xTAG assay.

  Primer   Sequence (5′--3′)           Genome location   Product size (bp)
  -------- --------------------------- ----------------- -------------------
  CDV-F    AACAGATGGGTGAAACAGCA        911\~921          97
  CDV-R    GCATAACTCCAGAGCAATGGGTAG    984\~1007         
  CPV-F    CAAGATAAAAGACGTGGTGTAACTC   928\~953          123
  CPV-R    TTGTGTAGACGCCTCAAAAGAATAA   1026\~1050        
  CAV-F    TTATGTCTATGGGAACCCTCACTG    2495\~2519        135
  CAV-R    CGAACACTTCAAACAAAACG        2609\~2629        
  CPIV-F   TTCTATTCTGCCTACGGATTGTTCT   1215\~1234        89
  CPIV-R   TCTCTACCCTTTCGATATCAGCTTC   1280\~1303        
  RV-F     CAGGDCTGGTATCGTTYACTGGGTT   50--75            158
  RV-R     GAARTGGRTGAAATAGGARTGAGG    183--207          
                                                         

The multiplex amplification was performed using a one-step RT-PCR assay kit (QIAGEN, Hilden, Germany) in a total volume of 50 μL as suggested by the manufacturer. The amplification steps were: 50°C for 30 min, 95°C for 15 min and 35 cycles of 94°C for 30 s, 60°C for 30 s, and 72°C for 30 s and a final step of 10 min at 72°C. All samples were tested in triplicate and all assays were run with positive and negative controls.

Hybridization and Luminex Analysis
----------------------------------

MagPlex-TAG microspheres were purchased from Luminex (Austin, TX, United States) and suspended in 1.1× tetramethylammonium chloride as outlined in the manufacturer's protocol. Nucleic acid hybridization was carried out in a 100 μL volume that included 5 μL of amplified product, 20 μL of the working microsphere mixture that contained 2500 beads of each target-specific microsphere and 75 μL SAPE. Hybridization was carried out at 45°C for 30 min. The products were analyzed using the Luminex 200 reader (Luminex) immediately after hybridization and the results were expressed as mean fluorescence intensity (MFI).

Specificity and Sensitivity Testing
-----------------------------------

Pseudorabies virus, CIV, and CCV samples were used as templates in amplification reactions to determine assay specificity. All amplified products were sequenced for verification (Sangon Biotech, Guangzhou, China). Sensitivity testing was carried out using PCR products from CDV, CPV, CAV, RV, and CPIV amplification that were cloned into the pGEM T easy vector (Promega, Madison, WI, United States). CDV, RV, and CPIV were *in vitro* transcribed using T7 RNA polymerase with the RiboMAX Large Scale RNA production kit (Promega) according to the manufacturer's instructions. RNase-free DNase (Promega) was used to remove plasmid DNA after transcription. TRIzol LS reagent (Invitrogen, Carlsbad, CA, United States) was used for RNA isolation according to the manufacturer's instructions. Genome copy numbers were calculated based on the nucleic acid concentration and molecular weight. Tenfold serial dilutions of DNA or RNA standards were used as assay templates. All the samples were tested in triplicate.

Sample Detection
----------------

Considering that most of the samples from SPF dogs or their living houses were tested negative, clinical samples from the animal hospital were needed to evaluate the xTAG assay. Clinical samples that included feces, saliva, throat swab, and urine from dogs were tested using conventional PCR (**Table [2](#T2){ref-type="table"}**) and the Luminex xTAG assay. Besides, artificial mixed infection samples (by mixing the positive nucleic acid together, or mixing the positive samples together before nucleic acid extraction) were tested for further validation of the xTAG assay. All samples were tested in duplicate. In addition, a comparative test was carried out using the CDV/CPV test card (Quicking Biotech, Shanghai, China) followed by the manufacturer's instructions.

###### 

Primers used for the conventional PCR method.

  Pathogen   Sequence 5′--3′                   Amplicon size (bp)
  ---------- --------------------------------- --------------------
  CPV-F      ATCACAGCAAACTCAAGCAGACTT          690
  CPV-R      AAATGGTGGTAAGCCCAATGCTC           
  CAV-F      TGTGCCCATCGACAAGGAA               433
  CAV-R      CTAATAGAAGCGGCCCAACTG             
  RV-F       GATCCTGATGAYGTATGTTCCTA           87
  RV-R       RGATTCCGTAGCTRGTCCA               
  CPIV-F     TACAATCCCACCTACAACA               265
  CPIV-R     GAATGATCCCTCCTCAAAGC              
  CDV-F      GCTTACTTCAGACTCGGGCAAGAAATGGTTA   154
  CDV-R      CAGTAGCTCGAATTGTCCGGTCCTCTGTTGT   
                                               

Data Analysis and Cutoff Definition
-----------------------------------

Mean fluorescence intensity values were calculated using software supplied with the Luminex reader after counting at least 100 beads for each bead set in a sample ([@B17]). Background calculations used blank controls containing all the hybridization components except target DNA or RNA. The cutoff value of each bead set was defined as the net MFI value of negative controls +3 SD as previously defined ([@B5]).

Results
=======

Nucleic acid of PRV, CIV, and CCV were used as templates in this study to evaluate the specificity of the multiplex-PCR primers. The results showed that, all primers pairs were found to detect their specific viral target with no amplification of non-target samples. The fluorescence signals were observed only in the positive controls (**Figure [1](#F1){ref-type="fig"}**), revealing a good specificity of the assay.

![Specificity analysis of the 5-plex Luminex xTAG assay. Each bar represents the average MFI of duplicate samples. CDV, canine distemper virus; CPV, canine parvovirus; CAV, canine adenovirus; CPIV, canine parainfluenza virus; RV, rabies virus; PRV, pseudorabies virus; CCV, canine coronavirus; CIV, canine influenza virus; NC, negative control (water). The result of the 5-plex Luminex xTAG assay showed high specificity.](fmicb-09-01783-g001){#F1}

Sensitivity was tested using 10-fold serial dilutions of standards and the limit of detection was defined as the highest dilution that resulted in an MFI value above the cutoff value. In this study, these five viruses shared different cutoff values, which were based on the MFI values of their own negative controls. Data analysis showed that the limit of detection for each of the five viruses was about 100 copies/μL (**Figure [2](#F2){ref-type="fig"}** and **Table [3](#T3){ref-type="table"}**).

![Sensitivity analysis of the xTAG assay. Cloned gene copies from the indicated viruses were transcribed *in vitro* and used in triplicate. The detection limit was 100 copies/μL for these five viruses.](fmicb-09-01783-g002){#F2}

###### 

MFI values of different recombinant plasmid concentrations.

  Sample (copies/μL)   CDV       CPV      CPIV     CAV      RV
  -------------------- --------- -------- -------- -------- --------
  10^8^                11394.5   8122.5   7085.5   9012.5   9619.6
  10^7^                9883      6535     6634.5   6944.5   7342
  10^6^                7262      4432     5311     4699     5849
  10^5^                5335      3319     4733     2638.5   4440.5
  10^4^                3879.5    2056     2891.5   1730.5   3214
  10^3^                2475      1312     1661     1144     2075
  10^2^                1552.5    791      707      497.5    1174
  10^1^                348       247      106      47.7     431
                                                            

The reproducibility and stability of the assay was determined using parallel reactions at concentrations of 10^8^, 10^5^, and 10^3^ copies/μL of standard DNA/RNA. The inter-assay variance was less than 3%, while the intra-assay variance was less than 4%. The low inter-assay and intra-assay coefficient of variations demonstrated a high repeatability of the xTAG assay (**Table [4](#T4){ref-type="table"}**).

###### 

Reproducibility and stability analysis of the Luminex xTAG assay.

  Virus   Copies/μL   Intra-assay MFI   CV%     Inter-assay MFI   CV%                            
  ------- ----------- ----------------- ------- ----------------- ------ ------- ------- ------- ------
  CDV     10^8^       10286             10723   10488             2.08   11501   10864   10711   3.80
          10^5^       5429              5623    5466              1.87   5418    5589    5703    2.57
          10^3^       2485              2395    2501              2.32   2386    2475    2529    2.93
  CPV     10^8^       8468              8153    8361              1.92   8218    8575    8165    2.68
          10^5^       3198              3396    3256              2.89   3295    3188    3426    3.61
          10^3^       1353              1298    1295              2.48   1346    1286    1285    2.67
  CAV     10^8^       7399              7291    7101              2.07   7047    7245    7435    2.68
          10^5^       2719              2693    2596              2.42   2548    2683    2714    3.33
          10^3^       1129              1167    1189              2.61   1135    1205    1145    3.26
  CPIV    10^8^       9225              9464    9048              2.25   9370    9167    9186    1.21
          10^5^       4849              4704    4627              2.38   4688    4754    4801    1.20
          10^3^       1663              1692    1630              1.87   1621    1684    1673    2.03
  RV      10^8^       9634              9714    9511              1.06   9743    9812    9569    1.28
          10^5^       4483              4513    4326              2.26   4512    4643    4486    1.85
          10^3^       2008              2093    1984              2.82   2043    1994    2063    3.94
                                                                                                 

A total number of 75 clinical samples were evaluated by both the Luminex xTAG assay and conventional PCR. The positive rates for CDV, CPV, CAV, and CPIV were 8% (6/75), 50.7% (38/75), 2.7% (2/75), and 4% (3/75), respectively. No sample tested positive for RV and no mixed infections were identified. The detection results of these two methods were in 100% agreement. The positive detection rate of CDV test card was 8% (6/75), which was fully consistent with the xTAG assay. However, only 35 samples were tested positive with the CPV test card, three positive samples (confirmed by sequencing) were falsely detected as negative. To a certain extent, the xTAG assay was more sensitive than the colloidal gold test strip, as revealed by the comparison results (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}).

To determine the utility of the multiplex xTAG assay in multiplex infection, artificial mixed infection samples were tested. Three samples were found triple infection and four samples were found double infection (**Figure [3](#F3){ref-type="fig"}**). Indicating that, the new developed multiplex xTAG assay had the ability to identify different targets in co-infection samples.

![Validation of the artificial mixed infection samples. 1, CPV and CAV positive sample; 2, CDV, CPV, and RV positive sample; 3, CAV and CPIV positive samples; 4, CDV and CAV positive sample; 5, CPIV and RV positive sample; 6, CDV, CPV, and CAV positive sample; 7, CPV, CPIV, and RV positive sample; 8, negative control.](fmicb-09-01783-g003){#F3}

Discussion
==========

The multiplex PCR format allows for the simultaneous detection of different nucleic acid sequences in a single reaction. This is time- and labor-saving, but the interpretation of conventional multiplex PCR relies on amplicon size, restricting its use in a high-throughput format ([@B16]). The Luminex xTAG platform was used in this study to develop specific and sensitive high-throughput assays that can be expanded to include more pathogens as needed ([@B9]). This format has been widely used in human disease diagnosis but not available in dogs ([@B21]; [@B7]; [@B10]).

Dogs are important experimental animals with strict quality control. CDV, CPV, CAV, and RV are the pathogens that must be excluded according to the national standard of laboratory animal in China. The xTAG technology was used to develop high throughput assays for the rapid and sensitive simultaneous detection of these viruses to help with laboratory dog's daily monitoring.

In this study, a 5-plex Luminex xTAG assay for the simultaneous detection of CDV, CPV, CPIV, CAV, and RV in a single reaction was developed and validated. This is the first report of a Luminex xTAG assay for use in canine pathogen identification, and it's expected to replace the currently existing single PCR method for canine daily monitoring. However, this panel may not be a good tool for clinical diagnosis, compared with the fast and easy point-of-care testing (POCT).

Primer design is the key for the establishment of Luminex xTAG assay. Unwanted hairpin structures would increase the MFI background. The bio-informatics analysis was applied to evaluate specificity and avoid primer dimers. Specific primers targeted conserved genomic regions for each virus were selected. This approach yielded an assay without cross-reactions between target and non-target viruses.

The limit of detection for the multiplex Luminex xTAG assay was estimated using viral DNA/RNA generated from cloned viral fragments. The assay sensitivity was 100 copies/μL, which might be slightly lower than real-time PCR ([@B19]). Validation of 75 clinical samples revealed a 100% coincidence rate with conventional PCR detection, indicating that the assay was sufficient for the detection of these five pathogens in clinical samples. Artificial mixed infection samples were verified, revealing that the assay was capable of identifying specific targets in co-infection samples.

In this study, a novel multiplex platform for the simultaneous detection of five important canine viral pathogens was established. This assay will be useful for animal health status and their living house monitoring. Additional targets can be integrated into the existing multiplex platform as needed and allows increased flexibility in disease investigation and environmental monitoring.
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